Why the market leader in umami acquired a Central Ohio gene therapy startup


We talked to an executive and an investor about the somewhat surprising deal for the young company.

Previous Absci inks deal worth potentially $650M with drug maker Almirall
Next A day after leaving Dish Network, CEO starts as head of real estate giant